US EditionCND Life Sciences Raises $13.5M in Series A3
Summary by FinSMEs
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
CND Life Sciences Raises $13.5M in Series A3
CND Life Sciences, a Scottsdale, AZ-based diagnostics company developing tools for the detection of neurodegenerative diseases, raised $13.5M in Series A3 funding. The round was led by VILAS Ventures. The company intends to use the funds to accelerate its commercial growth and R&D initiatives, expanding access to its flagship product, the Syn-One Test, the first […] The post CND Life Sciences Raises $13.5M in Series A3 appeared first on FinSMEs.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
